[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Chitin and Chitosan Derivatives Market Growth 2023-2029

February 2023 | 101 pages | ID: G896D1AF5C60EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Chitin and chitosan derivatives are naturally occurring polymers with a wide range of applications.

Chitin and chitosan derivatives are used as excipients and drug carriers in the pharmaceutical field.

LPI (LP Information)' newest research report, the “Chitin and Chitosan Derivatives Industry Forecast” looks at past sales and reviews total world Chitin and Chitosan Derivatives sales in 2022, providing a comprehensive analysis by region and market sector of projected Chitin and Chitosan Derivatives sales for 2023 through 2029. With Chitin and Chitosan Derivatives sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chitin and Chitosan Derivatives industry.

This Insight Report provides a comprehensive analysis of the global Chitin and Chitosan Derivatives landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chitin and Chitosan Derivatives portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Chitin and Chitosan Derivatives market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chitin and Chitosan Derivatives and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chitin and Chitosan Derivatives.

The global Chitin and Chitosan Derivatives market size is projected to grow from US$ 2399.2 million in 2022 to US$ 4402.3 million in 2029; it is expected to grow at a CAGR of 4402.3 from 2023 to 2029.

Chitin is the second largest biopolymer after cellulose with a wide range of applications. Chitin is a natural polymer derived from marine crustaceans, shrimps, crabs and other non-animal sources. It is produced through waste products from the seafood processing industry. Recently the demand for chitin and chitosan has increased due to its easy availability and easy production process. Properties such as its nontoxicity.

This report presents a comprehensive overview, market shares, and growth opportunities of Chitin and Chitosan Derivatives market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Glucosamine
  • Chitosan
  • Others
Segmentation by application
  • Water Treatment
  • Cosmetics & Toiletries
  • Food & Beverages
  • Healthcare/Medical
  • Agrochemicals
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Advanced Biopolymers AS (Norway)
  • FMC Corp. (US)
  • Golden-Shell Pharmaceutical Co.(China)
  • G.T.C. Bio Corporation (China)
  • KYTOSAN USA, LLC (US)
  • Kitozyme (Belgium)
  • Heppe Medical Chitosan GmbH (Germany)
  • Kunpoong Bio Co.(South Korea)
  • Meron Biopolymers (India)
  • Primex Ehf (Iceland)
  • Zhejiang Candorly Pharmaceutical Co.(China)
Key Questions Addressed in this Report

What is the 10-year outlook for the global Chitin and Chitosan Derivatives market?

What factors are driving Chitin and Chitosan Derivatives market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Chitin and Chitosan Derivatives market opportunities vary by end market size?

How does Chitin and Chitosan Derivatives break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Chitin and Chitosan Derivatives Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Chitin and Chitosan Derivatives by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Chitin and Chitosan Derivatives by Country/Region, 2018, 2022 & 2029
2.2 Chitin and Chitosan Derivatives Segment by Type
  2.2.1 Glucosamine
  2.2.2 Chitosan
  2.2.3 Others
2.3 Chitin and Chitosan Derivatives Sales by Type
  2.3.1 Global Chitin and Chitosan Derivatives Sales Market Share by Type (2018-2023)
  2.3.2 Global Chitin and Chitosan Derivatives Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Chitin and Chitosan Derivatives Sale Price by Type (2018-2023)
2.4 Chitin and Chitosan Derivatives Segment by Application
  2.4.1 Water Treatment
  2.4.2 Cosmetics & Toiletries
  2.4.3 Food & Beverages
  2.4.4 Healthcare/Medical
  2.4.5 Agrochemicals
2.5 Chitin and Chitosan Derivatives Sales by Application
  2.5.1 Global Chitin and Chitosan Derivatives Sale Market Share by Application (2018-2023)
  2.5.2 Global Chitin and Chitosan Derivatives Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Chitin and Chitosan Derivatives Sale Price by Application (2018-2023)

3 GLOBAL CHITIN AND CHITOSAN DERIVATIVES BY COMPANY

3.1 Global Chitin and Chitosan Derivatives Breakdown Data by Company
  3.1.1 Global Chitin and Chitosan Derivatives Annual Sales by Company (2018-2023)
  3.1.2 Global Chitin and Chitosan Derivatives Sales Market Share by Company (2018-2023)
3.2 Global Chitin and Chitosan Derivatives Annual Revenue by Company (2018-2023)
  3.2.1 Global Chitin and Chitosan Derivatives Revenue by Company (2018-2023)
  3.2.2 Global Chitin and Chitosan Derivatives Revenue Market Share by Company (2018-2023)
3.3 Global Chitin and Chitosan Derivatives Sale Price by Company
3.4 Key Manufacturers Chitin and Chitosan Derivatives Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Chitin and Chitosan Derivatives Product Location Distribution
  3.4.2 Players Chitin and Chitosan Derivatives Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR CHITIN AND CHITOSAN DERIVATIVES BY GEOGRAPHIC REGION

4.1 World Historic Chitin and Chitosan Derivatives Market Size by Geographic Region (2018-2023)
  4.1.1 Global Chitin and Chitosan Derivatives Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Chitin and Chitosan Derivatives Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Chitin and Chitosan Derivatives Market Size by Country/Region (2018-2023)
  4.2.1 Global Chitin and Chitosan Derivatives Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Chitin and Chitosan Derivatives Annual Revenue by Country/Region (2018-2023)
4.3 Americas Chitin and Chitosan Derivatives Sales Growth
4.4 APAC Chitin and Chitosan Derivatives Sales Growth
4.5 Europe Chitin and Chitosan Derivatives Sales Growth
4.6 Middle East & Africa Chitin and Chitosan Derivatives Sales Growth

5 AMERICAS

5.1 Americas Chitin and Chitosan Derivatives Sales by Country
  5.1.1 Americas Chitin and Chitosan Derivatives Sales by Country (2018-2023)
  5.1.2 Americas Chitin and Chitosan Derivatives Revenue by Country (2018-2023)
5.2 Americas Chitin and Chitosan Derivatives Sales by Type
5.3 Americas Chitin and Chitosan Derivatives Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Chitin and Chitosan Derivatives Sales by Region
  6.1.1 APAC Chitin and Chitosan Derivatives Sales by Region (2018-2023)
  6.1.2 APAC Chitin and Chitosan Derivatives Revenue by Region (2018-2023)
6.2 APAC Chitin and Chitosan Derivatives Sales by Type
6.3 APAC Chitin and Chitosan Derivatives Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Chitin and Chitosan Derivatives by Country
  7.1.1 Europe Chitin and Chitosan Derivatives Sales by Country (2018-2023)
  7.1.2 Europe Chitin and Chitosan Derivatives Revenue by Country (2018-2023)
7.2 Europe Chitin and Chitosan Derivatives Sales by Type
7.3 Europe Chitin and Chitosan Derivatives Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Chitin and Chitosan Derivatives by Country
  8.1.1 Middle East & Africa Chitin and Chitosan Derivatives Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Chitin and Chitosan Derivatives Revenue by Country (2018-2023)
8.2 Middle East & Africa Chitin and Chitosan Derivatives Sales by Type
8.3 Middle East & Africa Chitin and Chitosan Derivatives Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chitin and Chitosan Derivatives
10.3 Manufacturing Process Analysis of Chitin and Chitosan Derivatives
10.4 Industry Chain Structure of Chitin and Chitosan Derivatives

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Chitin and Chitosan Derivatives Distributors
11.3 Chitin and Chitosan Derivatives Customer

12 WORLD FORECAST REVIEW FOR CHITIN AND CHITOSAN DERIVATIVES BY GEOGRAPHIC REGION

12.1 Global Chitin and Chitosan Derivatives Market Size Forecast by Region
  12.1.1 Global Chitin and Chitosan Derivatives Forecast by Region (2024-2029)
  12.1.2 Global Chitin and Chitosan Derivatives Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Chitin and Chitosan Derivatives Forecast by Type
12.7 Global Chitin and Chitosan Derivatives Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Advanced Biopolymers AS (Norway)
  13.1.1 Advanced Biopolymers AS (Norway) Company Information
  13.1.2 Advanced Biopolymers AS (Norway) Chitin and Chitosan Derivatives Product Portfolios and Specifications
  13.1.3 Advanced Biopolymers AS (Norway) Chitin and Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Advanced Biopolymers AS (Norway) Main Business Overview
  13.1.5 Advanced Biopolymers AS (Norway) Latest Developments
13.2 FMC Corp. (US)
  13.2.1 FMC Corp. (US) Company Information
  13.2.2 FMC Corp. (US) Chitin and Chitosan Derivatives Product Portfolios and Specifications
  13.2.3 FMC Corp. (US) Chitin and Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 FMC Corp. (US) Main Business Overview
  13.2.5 FMC Corp. (US) Latest Developments
13.3 Golden-Shell Pharmaceutical Co.(China)
  13.3.1 Golden-Shell Pharmaceutical Co.(China) Company Information
  13.3.2 Golden-Shell Pharmaceutical Co.(China) Chitin and Chitosan Derivatives Product Portfolios and Specifications
  13.3.3 Golden-Shell Pharmaceutical Co.(China) Chitin and Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Golden-Shell Pharmaceutical Co.(China) Main Business Overview
  13.3.5 Golden-Shell Pharmaceutical Co.(China) Latest Developments
13.4 G.T.C. Bio Corporation (China)
  13.4.1 G.T.C. Bio Corporation (China) Company Information
  13.4.2 G.T.C. Bio Corporation (China) Chitin and Chitosan Derivatives Product Portfolios and Specifications
  13.4.3 G.T.C. Bio Corporation (China) Chitin and Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 G.T.C. Bio Corporation (China) Main Business Overview
  13.4.5 G.T.C. Bio Corporation (China) Latest Developments
13.5 KYTOSAN USA, LLC (US)
  13.5.1 KYTOSAN USA, LLC (US) Company Information
  13.5.2 KYTOSAN USA, LLC (US) Chitin and Chitosan Derivatives Product Portfolios and Specifications
  13.5.3 KYTOSAN USA, LLC (US) Chitin and Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 KYTOSAN USA, LLC (US) Main Business Overview
  13.5.5 KYTOSAN USA, LLC (US) Latest Developments
13.6 Kitozyme (Belgium)
  13.6.1 Kitozyme (Belgium) Company Information
  13.6.2 Kitozyme (Belgium) Chitin and Chitosan Derivatives Product Portfolios and Specifications
  13.6.3 Kitozyme (Belgium) Chitin and Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Kitozyme (Belgium) Main Business Overview
  13.6.5 Kitozyme (Belgium) Latest Developments
13.7 Heppe Medical Chitosan GmbH (Germany)
  13.7.1 Heppe Medical Chitosan GmbH (Germany) Company Information
  13.7.2 Heppe Medical Chitosan GmbH (Germany) Chitin and Chitosan Derivatives Product Portfolios and Specifications
  13.7.3 Heppe Medical Chitosan GmbH (Germany) Chitin and Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Heppe Medical Chitosan GmbH (Germany) Main Business Overview
  13.7.5 Heppe Medical Chitosan GmbH (Germany) Latest Developments
13.8 Kunpoong Bio Co.(South Korea)
  13.8.1 Kunpoong Bio Co.(South Korea) Company Information
  13.8.2 Kunpoong Bio Co.(South Korea) Chitin and Chitosan Derivatives Product Portfolios and Specifications
  13.8.3 Kunpoong Bio Co.(South Korea) Chitin and Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Kunpoong Bio Co.(South Korea) Main Business Overview
  13.8.5 Kunpoong Bio Co.(South Korea) Latest Developments
13.9 Meron Biopolymers (India)
  13.9.1 Meron Biopolymers (India) Company Information
  13.9.2 Meron Biopolymers (India) Chitin and Chitosan Derivatives Product Portfolios and Specifications
  13.9.3 Meron Biopolymers (India) Chitin and Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Meron Biopolymers (India) Main Business Overview
  13.9.5 Meron Biopolymers (India) Latest Developments
13.10 Primex Ehf (Iceland)
  13.10.1 Primex Ehf (Iceland) Company Information
  13.10.2 Primex Ehf (Iceland) Chitin and Chitosan Derivatives Product Portfolios and Specifications
  13.10.3 Primex Ehf (Iceland) Chitin and Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Primex Ehf (Iceland) Main Business Overview
  13.10.5 Primex Ehf (Iceland) Latest Developments
13.11 Zhejiang Candorly Pharmaceutical Co.(China)
  13.11.1 Zhejiang Candorly Pharmaceutical Co.(China) Company Information
  13.11.2 Zhejiang Candorly Pharmaceutical Co.(China) Chitin and Chitosan Derivatives Product Portfolios and Specifications
  13.11.3 Zhejiang Candorly Pharmaceutical Co.(China) Chitin and Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Zhejiang Candorly Pharmaceutical Co.(China) Main Business Overview
  13.11.5 Zhejiang Candorly Pharmaceutical Co.(China) Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Chitin and Chitosan Derivatives Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Chitin and Chitosan Derivatives Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Glucosamine
Table 4. Major Players of Chitosan
Table 5. Major Players of Others
Table 6. Global Chitin and Chitosan Derivatives Sales by Type (2018-2023) & (K MT)
Table 7. Global Chitin and Chitosan Derivatives Sales Market Share by Type (2018-2023)
Table 8. Global Chitin and Chitosan Derivatives Revenue by Type (2018-2023) & ($ million)
Table 9. Global Chitin and Chitosan Derivatives Revenue Market Share by Type (2018-2023)
Table 10. Global Chitin and Chitosan Derivatives Sale Price by Type (2018-2023) & (USD/MT)
Table 11. Global Chitin and Chitosan Derivatives Sales by Application (2018-2023) & (K MT)
Table 12. Global Chitin and Chitosan Derivatives Sales Market Share by Application (2018-2023)
Table 13. Global Chitin and Chitosan Derivatives Revenue by Application (2018-2023)
Table 14. Global Chitin and Chitosan Derivatives Revenue Market Share by Application (2018-2023)
Table 15. Global Chitin and Chitosan Derivatives Sale Price by Application (2018-2023) & (USD/MT)
Table 16. Global Chitin and Chitosan Derivatives Sales by Company (2018-2023) & (K MT)
Table 17. Global Chitin and Chitosan Derivatives Sales Market Share by Company (2018-2023)
Table 18. Global Chitin and Chitosan Derivatives Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Chitin and Chitosan Derivatives Revenue Market Share by Company (2018-2023)
Table 20. Global Chitin and Chitosan Derivatives Sale Price by Company (2018-2023) & (USD/MT)
Table 21. Key Manufacturers Chitin and Chitosan Derivatives Producing Area Distribution and Sales Area
Table 22. Players Chitin and Chitosan Derivatives Products Offered
Table 23. Chitin and Chitosan Derivatives Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Chitin and Chitosan Derivatives Sales by Geographic Region (2018-2023) & (K MT)
Table 27. Global Chitin and Chitosan Derivatives Sales Market Share Geographic Region (2018-2023)
Table 28. Global Chitin and Chitosan Derivatives Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Chitin and Chitosan Derivatives Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Chitin and Chitosan Derivatives Sales by Country/Region (2018-2023) & (K MT)
Table 31. Global Chitin and Chitosan Derivatives Sales Market Share by Country/Region (2018-2023)
Table 32. Global Chitin and Chitosan Derivatives Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Chitin and Chitosan Derivatives Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Chitin and Chitosan Derivatives Sales by Country (2018-2023) & (K MT)
Table 35. Americas Chitin and Chitosan Derivatives Sales Market Share by Country (2018-2023)
Table 36. Americas Chitin and Chitosan Derivatives Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Chitin and Chitosan Derivatives Revenue Market Share by Country (2018-2023)
Table 38. Americas Chitin and Chitosan Derivatives Sales by Type (2018-2023) & (K MT)
Table 39. Americas Chitin and Chitosan Derivatives Sales by Application (2018-2023) & (K MT)
Table 40. APAC Chitin and Chitosan Derivatives Sales by Region (2018-2023) & (K MT)
Table 41. APAC Chitin and Chitosan Derivatives Sales Market Share by Region (2018-2023)
Table 42. APAC Chitin and Chitosan Derivatives Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Chitin and Chitosan Derivatives Revenue Market Share by Region (2018-2023)
Table 44. APAC Chitin and Chitosan Derivatives Sales by Type (2018-2023) & (K MT)
Table 45. APAC Chitin and Chitosan Derivatives Sales by Application (2018-2023) & (K MT)
Table 46. Europe Chitin and Chitosan Derivatives Sales by Country (2018-2023) & (K MT)
Table 47. Europe Chitin and Chitosan Derivatives Sales Market Share by Country (2018-2023)
Table 48. Europe Chitin and Chitosan Derivatives Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Chitin and Chitosan Derivatives Revenue Market Share by Country (2018-2023)
Table 50. Europe Chitin and Chitosan Derivatives Sales by Type (2018-2023) & (K MT)
Table 51. Europe Chitin and Chitosan Derivatives Sales by Application (2018-2023) & (K MT)
Table 52. Middle East & Africa Chitin and Chitosan Derivatives Sales by Country (2018-2023) & (K MT)
Table 53. Middle East & Africa Chitin and Chitosan Derivatives Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Chitin and Chitosan Derivatives Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Chitin and Chitosan Derivatives Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Chitin and Chitosan Derivatives Sales by Type (2018-2023) & (K MT)
Table 57. Middle East & Africa Chitin and Chitosan Derivatives Sales by Application (2018-2023) & (K MT)
Table 58. Key Market Drivers & Growth Opportunities of Chitin and Chitosan Derivatives
Table 59. Key Market Challenges & Risks of Chitin and Chitosan Derivatives
Table 60. Key Industry Trends of Chitin and Chitosan Derivatives
Table 61. Chitin and Chitosan Derivatives Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Chitin and Chitosan Derivatives Distributors List
Table 64. Chitin and Chitosan Derivatives Customer List
Table 65. Global Chitin and Chitosan Derivatives Sales Forecast by Region (2024-2029) & (K MT)
Table 66. Global Chitin and Chitosan Derivatives Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Chitin and Chitosan Derivatives Sales Forecast by Country (2024-2029) & (K MT)
Table 68. Americas Chitin and Chitosan Derivatives Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Chitin and Chitosan Derivatives Sales Forecast by Region (2024-2029) & (K MT)
Table 70. APAC Chitin and Chitosan Derivatives Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Chitin and Chitosan Derivatives Sales Forecast by Country (2024-2029) & (K MT)
Table 72. Europe Chitin and Chitosan Derivatives Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Chitin and Chitosan Derivatives Sales Forecast by Country (2024-2029) & (K MT)
Table 74. Middle East & Africa Chitin and Chitosan Derivatives Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Chitin and Chitosan Derivatives Sales Forecast by Type (2024-2029) & (K MT)
Table 76. Global Chitin and Chitosan Derivatives Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Chitin and Chitosan Derivatives Sales Forecast by Application (2024-2029) & (K MT)
Table 78. Global Chitin and Chitosan Derivatives Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Advanced Biopolymers AS (Norway) Basic Information, Chitin and Chitosan Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 80. Advanced Biopolymers AS (Norway) Chitin and Chitosan Derivatives Product Portfolios and Specifications
Table 81. Advanced Biopolymers AS (Norway) Chitin and Chitosan Derivatives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Advanced Biopolymers AS (Norway) Main Business
Table 83. Advanced Biopolymers AS (Norway) Latest Developments
Table 84. FMC Corp. (US) Basic Information, Chitin and Chitosan Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 85. FMC Corp. (US) Chitin and Chitosan Derivatives Product Portfolios and Specifications
Table 86. FMC Corp. (US) Chitin and Chitosan Derivatives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. FMC Corp. (US) Main Business
Table 88. FMC Corp. (US) Latest Developments
Table 89. Golden-Shell Pharmaceutical Co.(China) Basic Information, Chitin and Chitosan Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 90. Golden-Shell Pharmaceutical Co.(China) Chitin and Chitosan Derivatives Product Portfolios and Specifications
Table 91. Golden-Shell Pharmaceutical Co.(China) Chitin and Chitosan Derivatives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Golden-Shell Pharmaceutical Co.(China) Main Business
Table 93. Golden-Shell Pharmaceutical Co.(China) Latest Developments
Table 94. G.T.C. Bio Corporation (China) Basic Information, Chitin and Chitosan Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 95. G.T.C. Bio Corporation (China) Chitin and Chitosan Derivatives Product Portfolios and Specifications
Table 96. G.T.C. Bio Corporation (China) Chitin and Chitosan Derivatives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. G.T.C. Bio Corporation (China) Main Business
Table 98. G.T.C. Bio Corporation (China) Latest Developments
Table 99. KYTOSAN USA, LLC (US) Basic Information, Chitin and Chitosan Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 100. KYTOSAN USA, LLC (US) Chitin and Chitosan Derivatives Product Portfolios and Specifications
Table 101. KYTOSAN USA, LLC (US) Chitin and Chitosan Derivatives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. KYTOSAN USA, LLC (US) Main Business
Table 103. KYTOSAN USA, LLC (US) Latest Developments
Table 104. Kitozyme (Belgium) Basic Information, Chitin and Chitosan Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 105. Kitozyme (Belgium) Chitin and Chitosan Derivatives Product Portfolios and Specifications
Table 106. Kitozyme (Belgium) Chitin and Chitosan Derivatives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Kitozyme (Belgium) Main Business
Table 108. Kitozyme (Belgium) Latest Developments
Table 109. Heppe Medical Chitosan GmbH (Germany) Basic Information, Chitin and Chitosan Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 110. Heppe Medical Chitosan GmbH (Germany) Chitin and Chitosan Derivatives Product Portfolios and Specifications
Table 111. Heppe Medical Chitosan GmbH (Germany) Chitin and Chitosan Derivatives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. Heppe Medical Chitosan GmbH (Germany) Main Business
Table 113. Heppe Medical Chitosan GmbH (Germany) Latest Developments
Table 114. Kunpoong Bio Co.(South Korea) Basic Information, Chitin and Chitosan Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 115. Kunpoong Bio Co.(South Korea) Chitin and Chitosan Derivatives Product Portfolios and Specifications
Table 116. Kunpoong Bio Co.(South Korea) Chitin and Chitosan Derivatives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 117. Kunpoong Bio Co.(South Korea) Main Business
Table 118. Kunpoong Bio Co.(South Korea) Latest Developments
Table 119. Meron Biopolymers (India) Basic Information, Chitin and Chitosan Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 120. Meron Biopolymers (India) Chitin and Chitosan Derivatives Product Portfolios and Specifications
Table 121. Meron Biopolymers (India) Chitin and Chitosan Derivatives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 122. Meron Biopolymers (India) Main Business
Table 123. Meron Biopolymers (India) Latest Developments
Table 124. Primex Ehf (Iceland) Basic Information, Chitin and Chitosan Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 125. Primex Ehf (Iceland) Chitin and Chitosan Derivatives Product Portfolios and Specifications
Table 126. Primex Ehf (Iceland) Chitin and Chitosan Derivatives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 127. Primex Ehf (Iceland) Main Business
Table 128. Primex Ehf (Iceland) Latest Developments
Table 129. Zhejiang Candorly Pharmaceutical Co.(China) Basic Information, Chitin and Chitosan Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 130. Zhejiang Candorly Pharmaceutical Co.(China) Chitin and Chitosan Derivatives Product Portfolios and Specifications
Table 131. Zhejiang Candorly Pharmaceutical Co.(China) Chitin and Chitosan Derivatives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 132. Zhejiang Candorly Pharmaceutical Co.(China) Main Business
Table 133. Zhejiang Candorly Pharmaceutical Co.(China) Latest Developments

LIST OF FIGURES

Figure 1. Picture of Chitin and Chitosan Derivatives
Figure 2. Chitin and Chitosan Derivatives Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chitin and Chitosan Derivatives Sales Growth Rate 2018-2029 (K MT)
Figure 7. Global Chitin and Chitosan Derivatives Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Chitin and Chitosan Derivatives Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Glucosamine
Figure 10. Product Picture of Chitosan
Figure 11. Product Picture of Others
Figure 12. Global Chitin and Chitosan Derivatives Sales Market Share by Type in 2022
Figure 13. Global Chitin and Chitosan Derivatives Revenue Market Share by Type (2018-2023)
Figure 14. Chitin and Chitosan Derivatives Consumed in Water Treatment
Figure 15. Global Chitin and Chitosan Derivatives Market: Water Treatment (2018-2023) & (K MT)
Figure 16. Chitin and Chitosan Derivatives Consumed in Cosmetics & Toiletries
Figure 17. Global Chitin and Chitosan Derivatives Market: Cosmetics & Toiletries (2018-2023) & (K MT)
Figure 18. Chitin and Chitosan Derivatives Consumed in Food & Beverages
Figure 19. Global Chitin and Chitosan Derivatives Market: Food & Beverages (2018-2023) & (K MT)
Figure 20. Chitin and Chitosan Derivatives Consumed in Healthcare/Medical
Figure 21. Global Chitin and Chitosan Derivatives Market: Healthcare/Medical (2018-2023) & (K MT)
Figure 22. Chitin and Chitosan Derivatives Consumed in Agrochemicals
Figure 23. Global Chitin and Chitosan Derivatives Market: Agrochemicals (2018-2023) & (K MT)
Figure 24. Global Chitin and Chitosan Derivatives Sales Market Share by Application (2022)
Figure 25. Global Chitin and Chitosan Derivatives Revenue Market Share by Application in 2022
Figure 26. Chitin and Chitosan Derivatives Sales Market by Company in 2022 (K MT)
Figure 27. Global Chitin and Chitosan Derivatives Sales Market Share by Company in 2022
Figure 28. Chitin and Chitosan Derivatives Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Chitin and Chitosan Derivatives Revenue Market Share by Company in 2022
Figure 30. Global Chitin and Chitosan Derivatives Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Chitin and Chitosan Derivatives Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Chitin and Chitosan Derivatives Sales 2018-2023 (K MT)
Figure 33. Americas Chitin and Chitosan Derivatives Revenue 2018-2023 ($ Millions)
Figure 34. APAC Chitin and Chitosan Derivatives Sales 2018-2023 (K MT)
Figure 35. APAC Chitin and Chitosan Derivatives Revenue 2018-2023 ($ Millions)
Figure 36. Europe Chitin and Chitosan Derivatives Sales 2018-2023 (K MT)
Figure 37. Europe Chitin and Chitosan Derivatives Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Chitin and Chitosan Derivatives Sales 2018-2023 (K MT)
Figure 39. Middle East & Africa Chitin and Chitosan Derivatives Revenue 2018-2023 ($ Millions)
Figure 40. Americas Chitin and Chitosan Derivatives Sales Market Share by Country in 2022
Figure 41. Americas Chitin and Chitosan Derivatives Revenue Market Share by Country in 2022
Figure 42. Americas Chitin and Chitosan Derivatives Sales Market Share by Type (2018-2023)
Figure 43. Americas Chitin and Chitosan Derivatives Sales Market Share by Application (2018-2023)
Figure 44. United States Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Chitin and Chitosan Derivatives Sales Market Share by Region in 2022
Figure 49. APAC Chitin and Chitosan Derivatives Revenue Market Share by Regions in 2022
Figure 50. APAC Chitin and Chitosan Derivatives Sales Market Share by Type (2018-2023)
Figure 51. APAC Chitin and Chitosan Derivatives Sales Market Share by Application (2018-2023)
Figure 52. China Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Chitin and Chitosan Derivatives Sales Market Share by Country in 2022
Figure 60. Europe Chitin and Chitosan Derivatives Revenue Market Share by Country in 2022
Figure 61. Europe Chitin and Chitosan Derivatives Sales Market Share by Type (2018-2023)
Figure 62. Europe Chitin and Chitosan Derivatives Sales Market Share by Application (2018-2023)
Figure 63. Germany Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Chitin and Chitosan Derivatives Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Chitin and Chitosan Derivatives Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Chitin and Chitosan Derivatives Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Chitin and Chitosan Derivatives Sales Market Share by Application (2018-2023)
Figure 72. Egypt Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Chitin and Chitosan Derivatives Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Chitin and Chitosan Derivatives in 2022
Figure 78. Manufacturing Process Analysis of Chitin and Chitosan Derivatives
Figure 79. Industry Chain Structure of Chitin and Chitosan Derivatives
Figure 80. Channels of Distribution
Figure 81. Global Chitin and Chitosan Derivatives Sales Market Forecast by Region (2024-2029)
Figure 82. Global Chitin and Chitosan Derivatives Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Chitin and Chitosan Derivatives Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Chitin and Chitosan Derivatives Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Chitin and Chitosan Derivatives Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Chitin and Chitosan Derivatives Revenue Market Share Forecast by Application (2024-2029)


More Publications